- Lobbying
- Lobbying by Hologic, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Colin Roskey | Health Policy Advisor and Counsel, Senate Finance Committee |
Marilyn Yager | Dep. Ass't to the Pres., White House Office of Public Liason |
Elinor Hiller | Senior Advisor, Office of the Administrator, Centers for Medicare & Medicaid Services (CMS); Director, Medicare Parts C and D Analysis Group, Office of Legislation, CMS. Senior Advisor, Office of the Administrator, Centers for Medicare & Medicaid Services (CMS); Director, Medicare Parts C and D Analysis Group, Office of Legislation, CMS. |
Mark Rayder | LA, Rep. Tom Latham; LA, Rep. Rodney Frelinghuysen; District Representative, Rep. Dean Gallo |
Regina Sherick | Staff Assistant, Senate Finance Committee |
Y. Brian Lee | Legislative Intern, Rep. Doug Lamborn (R-CO) |
Jane Lucas | Special Assistant to the President, White House Office of Legislative Affairs; Principal Deputy Director, IOS-Office of Health Reform, HHS; Legislative Director, Sen. John Thune (R-SD). All lobbying activities conducted in compliance with EO 13770. |
Peter J. Eckrich | LA, Sen. Mike Rounds; LA, Rep. Kristi Noem. |
James Paluskiewicz | Chief Counsel, House Health Subcommittee; Professional Staff, House Energy & Commerce Committee; Legislative Dir./Dep. Chief of Staff, Rep. Michael Burgess; Legislative Dir., Rep. Charlie Norwood; Legislative Correspondent, Rep. Stephanie Tubbs Jones Chief Counsel, House Health Subcommittee; Professional Staff, House Energy & Commerce Committee; Legislative Dir./Deputy Chief of Staff, Rep. Michael Burgess; Legislative Dir., Rep. Charlie Norwood; Legislative Correspondent, Rep. Tubbs Jones. |
Joyce Gresko | n/a |
Gina Sherick | n/a |
Marily Yager | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
Labor - Dept of (DOL)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
Labor - Dept of (DOL)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
Labor - Dept of (DOL)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
Labor - Dept of (DOL)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
Labor - Dept of (DOL)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
Labor - Dept of (DOL)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
Labor - Dept of (DOL)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
Labor - Dept of (DOL)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
Labor - Dept of (DOL)
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Commerce - Dept of (DOC)
Type of Issue
Medical
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Centers For Medicare and Medicaid Services (CMS)
Food & Drug Administration (FDA)
Type of Issue
Medical
Medicare
Registration
Issue(s) they said they’d lobby about: Women's health, prevention, diagnostic and imaging issues..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate